secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001104659-23-059829
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals prices $75M public offering of common stock at $39.50 per share
--------------------------------------------------------------------------------

- Offering of 1,898,735 shares at $39.50/share; gross proceeds ~$75M before expenses.
- Underwriter granted 30-day option to purchase up to 284,810 additional shares.
- Closing expected on or about May 16, 2023, subject to customary conditions.
- Guggenheim Securities is lead book-running manager; Truist Securities also book-runner; H.C. Wainwright lead manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000110465923059829/0001104659-23-059829-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000110465923059829/tm2315239d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-059829

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer